Post-COVID-vaccine autoimmune/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis.

Das, L; Bhadada, S K; Sood, A

Das, L; Bhadada, S K; Sood, A.

Affiliation

Das L; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, 1008, Nehru Extension Block, Chandigarh, 160012, India.
Bhadada SK; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, 1008, Nehru Extension Block, Chandigarh, 160012, India. bhadadask@rediffmail.com.
Sood A; Department of Nuclear Medicine, PGIMER, Chandigarh, India.

J Endocrinol Invest ; 45(2): 465-467, 2022 Feb.

Article in En | MEDLINE | ID: mdl-34585363

Subject(s)

Adjuvants, Immunologic; COVID-19/prevention & control; ChAdOx1 nCoV-19; Thyroid Gland/diagnostic imaging; Thyroiditis, Autoimmune; Adjuvants, Immunologic/administration & dosage; Adjuvants, Immunologic/adverse effects; COVID-19/epidemiology; ChAdOx1 nCoV-19/administration & dosage; ChAdOx1 nCoV-19/adverse effects; Female; Humans; Immunogenicity, Vaccine; Middle Aged; Patient Care Management/methods; SARS-CoV-2; Thyroid Function Tests/methods; Thyroiditis, Autoimmune/chemically induced; Thyroiditis, Autoimmune/diagnosis; Thyroiditis, Autoimmune/physiopathology; Thyroiditis, Autoimmune/therapy; Tomography, Emission-Computed/methods; Treatment Outcome

Key words

ASIA syndrome; COVID vaccine; Subacute thyroiditis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroid Gland / Thyroiditis, Autoimmune / Adjuvants, Immunologic / COVID-19 / ChAdOx1 nCoV-19 Type of study: Diagnostic_studies Language: En Journal: J Endocrinol Invest Year: 2022 Type: Article Affiliation country: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google